Download the Agenda

Speaker Information

 Christophe Quéva
Christophe Quéva CSO iTeos Therapeutics

Main Conference Day 1

11:00 PM Preclinical Development of PF-06840003: A Novel IDO1 Inhibitor

Hear about this novel IDO 1 inhibitor with promising in vivo efficacy and predicted human pharmacokinetic properties

Sponsorship Opportunities

Resource Center

Visit the Resource Center for complimentary industry related content!


Become a Pharma IQ Member and receive our weekly newsletter!